{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:23:18Z","timestamp":1793694198292,"version":"4.5.1"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T00:00:00Z","timestamp":1593043200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T00:00:00Z","timestamp":1593043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["643434"],"award-info":[{"award-number":["643434"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Major infectious disease outbreaks are a constant threat to human health. Clinical research responses to outbreaks generate evidence to improve outcomes and outbreak control. Experiences from previous epidemics have identified multiple challenges to undertaking timely clinical research responses. This scoping review is a systematic appraisal of political, economic, administrative, regulatory, logistical, ethical and social (PEARLES) challenges to clinical research responses to emergency epidemics and solutions identified to address these.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A scoping review. We searched six databases (MEDLINE, Embase, Global Health, PsycINFO, Scopus and Epistemonikos) for articles published from 2008 to July 2018. We included publications reporting PEARLES challenges to clinical research responses to emerging epidemics and pandemics and solutions identified to address these. Two reviewers screened articles for inclusion, extracted and analysed the data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 2678 articles screened, 76 were included. Most presented data relating to the 2014\u20132016 Ebola virus outbreak or the H1N1 outbreak in 2009. The articles related to clinical research responses in Africa (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200937), Europe (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20098), North America (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20095), Latin America and the Caribbean (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20093) and Asia (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091) and\/or globally (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200922). A wide range of solutions to PEARLES challenges was presented, including a need to strengthen global collaborations and coordination at all levels and develop pre-approved protocols and equitable frameworks, protocols and standards for emergencies. Clinical trial networks and expedited funding and approvals were some solutions implemented. National ownership and community engagement from the outset were a key enabler for delivery. Despite the wide range of recommended solutions, none had been formally evaluated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>To strengthen global preparedness and response to the COVID-19 pandemic and future epidemics, identified solutions for rapid clinical research deployment, delivery, and dissemination must be implemented. Improvements are urgently needed to strengthen collaborations, funding mechanisms, global and national research capacity and capability, targeting regions vulnerable to epidemics and pandemics. Solutions need to be flexible to allow timely adaptations to context, and research led by governments of affected regions. Research communities globally need to evaluate their activities and incorporate lessons learnt to refine and rehearse collaborative outbreak response plans in between epidemics.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12916-020-01624-8","type":"journal-article","created":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T09:02:43Z","timestamp":1593075763000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Addressing challenges for clinical research responses to emerging epidemics and pandemics: a scoping review"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2764-1177","authenticated-orcid":false,"given":"Louise","family":"Sigfrid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Maskell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.","family":"Bannister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharif A.","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelui","family":"Collinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadie","family":"Regmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Blackmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli","family":"Harriss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kajsa-Stina","family":"Longuere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Gobat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Horby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail","family":"Carson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,25]]},"reference":[{"issue":"13","key":"1624_CR1","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1056\/NEJMsb1209510","volume":"368","author":"N Lurie","year":"2013","unstructured":"Lurie N, Manolio T, Patterson AP, Collins F, Frieden T. Research as a part of public health emergency response. N Engl J Med. 2013;368(13):1251\u20135.","journal-title":"N Engl J Med"},{"issue":"4 Suppl","key":"1624_CR2","doi-asserted-by":"crossref","first-page":"e138","DOI":"10.1097\/CCM.0b013e3181cbaff4","volume":"38","author":"D Cook","year":"2010","unstructured":"Cook D, Burns K, Finfer S, Kissoon N, Bhagwanjee S, Annane D, et al. Clinical research ethics for critically ill patients: a pandemic proposal. Crit Care Med. 2010;38(4 Suppl):e138\u201342.","journal-title":"Crit Care Med"},{"issue":"1","key":"1624_CR3","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.antiviral.2008.01.152","volume":"78","author":"DG Bausch","year":"2008","unstructured":"Bausch DG, Sprecher AG, Jeffs B, Boumandouki P. Treatment of Marburg and Ebola hemorrhagic fevers: a strategy for testing new drugs and vaccines under outbreak conditions. Antivir Res. 2008;78(1):150\u201361.","journal-title":"Antivir Res"},{"issue":"9","key":"1624_CR4","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1093\/cid\/cix1061","volume":"66","author":"AM Rojek","year":"2018","unstructured":"Rojek AM, Dunning J, Leliogdowicz A, Castle L, Van Lieshout M, Carson G, et al. Regulatory and operational complexities of conducting a clinical treatment trial during an Ebola virus disease epidemic. Clin Infect Dis. 2018;66(9):1454\u20137.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1624_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-8847.2008.00239.x","volume":"10","author":"ER Ezeome","year":"2010","unstructured":"Ezeome ER, Simon C. Ethical problems in conducting research in acute epidemics: the Pfizer meningitis study in Nigeria as an illustration. Dev World Bioeth. 2010;10(1):1\u201310.","journal-title":"Dev World Bioeth."},{"issue":"1","key":"1624_CR6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00134-011-2409-8","volume":"38","author":"D Annane","year":"2012","unstructured":"Annane D, Antona M, Lehmann B, Kedzia C, Chevret S, Investigators C, et al. Designing and conducting a randomized trial for pandemic critical illness: the 2009 H1N1 influenza pandemic. Intensive Care Med. 2012;38(1):29\u201339.","journal-title":"Intensive Care Med"},{"issue":"9","key":"1624_CR7","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1080\/14760584.2016.1188695","volume":"15","author":"MP Kieny","year":"2016","unstructured":"Kieny MP, Rago L. Regulatory policy for research and development of vaccines for public health emergencies. Expert Rev Vaccines. 2016;15(9):1075\u20137.","journal-title":"Expert Rev Vaccines"},{"key":"1624_CR8","volume-title":"Connecting and mapping: exploring the capacities, capabilities, and barriers to a rapid response to outbreaks among funders and research networks Global Research Collaboration for Infectious Disease Preparedness (GloPID-R)","author":"GLOPID-R","year":"2016","unstructured":"GLOPID-R. Connecting and mapping: exploring the capacities, capabilities, and barriers to a rapid response to outbreaks among funders and research networks Global Research Collaboration for Infectious Disease Preparedness (GloPID-R) 2016."},{"issue":"7","key":"1624_CR9","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467\u201373.","journal-title":"Ann Intern Med"},{"key":"1624_CR10","first-page":"Mr000005","volume":"11","author":"RW Scherer","year":"2018","unstructured":"Scherer RW, Meerpohl JJ, Pfeifer N, Schmucker C, Schwarzer G, von Elm E. Full publication of results initially presented in abstracts. Cochrane Database Syst Rev. 2018;11:Mr000005.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"1624_CR11","first-page":"531","volume":"106","author":"WM Bramer","year":"2018","unstructured":"Bramer WM, de Jonge GB, Rethlefsen ML, Mast F, Kleijnen J. A systematic approach to searching: an efficient and complete method to develop literature searches. J Med Libr Assoc. 2018;106(4):531\u201341.","journal-title":"J Med Libr Assoc"},{"key":"1624_CR12","unstructured":"Cochrane. Cochrane handbook for systematic reviews of interventions. 5.1.0 ed. Cochrane, editor 2011."},{"key":"1624_CR13","doi-asserted-by":"crossref","unstructured":"Gostin LO, Tomori O, Wibulpolprasert S, Jha AK, Frenk J, Moon S, et al. Toward a common secure future: four global commissions in the wake of ebola. PLoS Med. 2016;13(5).","DOI":"10.1371\/journal.pmed.1002042"},{"issue":"9","key":"1624_CR14","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/cid\/cix1032","volume":"66","author":"SS Ellenberg","year":"2018","unstructured":"Ellenberg SS, Keusch GT, Babiker AG, Edwards KM, Lewis RJ, Lundgren JD, et al. Rigorous clinical trial design in public health emergencies is essential. Clin Infect Dis. 2018;66(9):1467\u20139.","journal-title":"Clin Infect Dis"},{"key":"1624_CR15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jcrc.2017.02.009","volume":"40","author":"AH Rishu","year":"2017","unstructured":"Rishu AH, Marinoff N, Julien L, Dumitrascu M, Marten N, Eggertson S, et al. Time required to initiate outbreak and pandemic observational research. J Crit Care. 2017;40:7\u201310.","journal-title":"J Crit Care"},{"key":"1624_CR16","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.conctc.2016.06.008","volume":"4","author":"J Doe-Anderson","year":"2016","unstructured":"Doe-Anderson J, Baseler B, Driscoll P, Johnson M, Lysander J, McNay L, et al. Beating the odds: successful establishment of a phase II\/III clinical research trial in resource-poor Liberia during the largest-ever Ebola outbreak. Contemp Clin Trials Commun. 2016;4:68\u201373.","journal-title":"Contemp Clin Trials Commun"},{"key":"1624_CR17","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s12879-015-0950-8","volume":"15","author":"MO Folayan","year":"2015","unstructured":"Folayan MO, Brown B, Haire B, Yakubu A, Peterson K, Tegli J. Stakeholders\u2019 engagement with Ebola therapy research in resource limited settings. BMC Infect Dis. 2015;15:242.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"1624_CR18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12910-017-0201-1","volume":"18","author":"E Alirol","year":"2017","unstructured":"Alirol E, Kuesel AC, Guraiib MM, de la Fuente-Nunez V, Saxena A, Gomes MF. Ethics review of studies during public health emergencies - the experience of the WHO ethics review committee during the Ebola virus disease epidemic. [Erratum appears in BMC Med Ethics. 2017 Jul 12;18(1):45; PMID: 28701168]. BMC Med Ethics. 2017;18(1):43.","journal-title":"BMC Med Ethics"},{"key":"1624_CR19","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.coviro.2016.03.008","volume":"17","author":"AM Henao-Restrepo","year":"2016","unstructured":"Henao-Restrepo AM, Preziosi MP, Wood D, Moorthy V, Kieny MP, WHO Ebola Research DT. On a path to accelerate access to Ebola vaccines: the WHO\u2019s research and development efforts during the 2014-2016 Ebola epidemic in West Africa. Curr Opin Virol. 2016;17:138\u201344.","journal-title":"Curr Opin Virol"},{"issue":"1","key":"1624_CR20","doi-asserted-by":"crossref","first-page":"1398485","DOI":"10.1080\/16549716.2017.1398485","volume":"10","author":"A Wilder-Smith","year":"2017","unstructured":"Wilder-Smith A, Preet R, Renhorn KE, Ximenes RA, Rodrigues LC, Solomon T, et al. ZikaPLAN: Zika Preparedness Latin American Network. Glob Health Action. 2017;10(1):1398485.","journal-title":"Glob Health Action"},{"issue":"5","key":"1624_CR21","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1128\/JCM.00053-17","volume":"55","author":"NR Pollock","year":"2017","unstructured":"Pollock NR, Wonderly B. Evaluating novel diagnostics in an outbreak setting: lessons learned from Ebola. J Clin Microbiol. 2017;55(5):1255\u201361.","journal-title":"J Clin Microbiol"},{"key":"1624_CR22","doi-asserted-by":"crossref","unstructured":"Canario Guzman JA, Espinal R, Baez J, Melgen RE, Perez Rosario PA, Mendoza ER. Ethical challenges for international collaborative research partnerships in the context of the Zika outbreak in the Dominican Republic: a qualitative case study. Health Res Policy Syst. 2017;15(82).","DOI":"10.1186\/s12961-017-0246-0"},{"issue":"5 Supplement 1","key":"1624_CR23","first-page":"276","volume":"97","author":"F Coulibaly","year":"2017","unstructured":"Coulibaly F, Haidara FC, Diallo F, Doumbia M, Traore Y, Tapia M, et al. Conducting clinical trials in crisis settings, 2012 military coup in Mali and the Ebola virus outbreak in 2014 in West Africa. Am J Trop Med Hygiene. 2017;97(5 Supplement 1):276.","journal-title":"Am J Trop Med Hygiene"},{"issue":"10034","key":"1624_CR24","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(16)30604-3","volume":"387","author":"L Matthiessen","year":"2016","unstructured":"Matthiessen L, Colli W, Delfraissy JF, Hwang ES, Mphahlele J, Ouellette M. Coordinating funding in public health emergencies. Lancet. 2016;387(10034):2197\u20138.","journal-title":"Lancet"},{"issue":"1","key":"1624_CR25","first-page":"66","volume":"13","author":"J Schieffelin","year":"2016","unstructured":"Schieffelin J, Moses LM, Shaffer J, Goba A, Grant DS. Clinical validation trial of a diagnostic for Ebola Zaire antigen detection: design rationale and challenges to implementation. Clin. 2016;13(1):66\u201372.","journal-title":"Clin."},{"issue":"10088","key":"1624_CR26","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1016\/S0140-6736(17)31602-1","volume":"389","author":"GT Keusch","year":"2017","unstructured":"Keusch GT, McAdam KPWJ. Clinical trials during epidemics. Lancet. 2017;389(10088):2455\u20137.","journal-title":"Lancet"},{"issue":"10009","key":"1624_CR27","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/S0140-6736(15)00946-0","volume":"386","author":"S Moon","year":"2015","unstructured":"Moon S, Sridhar D, Pate MA, Jha AK, Clinton C, Delaunay S, et al. Will Ebola change the game? Ten essential reforms before the next pandemic. The report of the Harvard-LSHTM Independent Panel on the Global Response to Ebola. Lancet. 2015;386(10009):2204\u201321.","journal-title":"Lancet"},{"issue":"2","key":"1624_CR28","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/dewb.12118","volume":"17","author":"DJ Hurst","year":"2017","unstructured":"Hurst DJ. Benefit sharing in a global context: working towards solutions for implementation. Dev World Bioeth. 2017;17(2):70\u20136.","journal-title":"Dev World Bioeth"},{"issue":"Supplement 1","key":"1624_CR29","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1093\/infdis\/jix657","volume":"217","author":"RJ Carter","year":"2018","unstructured":"Carter RJ, Idriss A, Widdowson MA, Samai M, Schrag SJ, Legardy-Williams JK, et al. Implementing a multisite clinical trial in the midst of an Ebola outbreak: lessons learned from the Sierra Leone Trial to introduce a vaccine against Ebola. J Infect Dis. 2018;217(Supplement 1):S16\u201323.","journal-title":"J Infect Dis"},{"issue":"1","key":"1624_CR30","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.antiviral.2007.10.008","volume":"78","author":"ES Higgs","year":"2008","unstructured":"Higgs ES, Hayden FG, Chotpitayasunondh T, Whitworth J, Farrar J. The Southeast Asian Influenza Clinical Research Network: development and challenges for a new multilateral research endeavor. Antivir Res. 2008;78(1):64\u20138.","journal-title":"Antivir Res"},{"issue":"2","key":"1624_CR31","doi-asserted-by":"crossref","first-page":"253","DOI":"10.4269\/ajtmh.15-0366","volume":"94","author":"OA Koita","year":"2016","unstructured":"Koita OA, Murphy RL, Fongoro S, Diallo B, Doumbia SO, Traore M, et al. Perspective piece clinical research and the training of host country investigators: essential health priorities for disease-endemic regions. Am J Trop Med Hyg. 2016;94(2):253\u20137.","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"1624_CR32","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4269\/ajtmh.16-1015","volume":"97","author":"GS Larson","year":"2017","unstructured":"Larson GS, Baseler BR, Hoover ML, Pierson JF, Tegli JK, Johnson MP, et al. Conventional wisdom versus actual outcomes: challenges in the conduct of an ebola vaccine trial in Liberia during the international public health emergency. Am J Trop Med Hyg. 2017;97(1):10\u20135.","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"1624_CR33","first-page":"545","volume":"8","author":"G Ruiz-Palacios","year":"2011","unstructured":"Ruiz-Palacios G, Guerrero ML, Galindo-Fraga A, Flores F, Ramirez A, Rafael SK, et al. La red: the formation of an emerging infectious diseases clinical research network in Mexico. Clin. 2011;8(4):545\u20136.","journal-title":"Clin."},{"key":"1624_CR34","unstructured":"Mitra A, Sethi N. Conducting research in the context of global health emergencies: identifying key ethical and governance issues. Nuffield Council onBioethics. 2016. Available at: https:\/\/www.nuffieldbioethics.org\/assets\/pdfs\/Research-in-global-health-emergencies-background-paper.pdf (Report)."},{"issue":"3","key":"1624_CR35","doi-asserted-by":"crossref","first-page":"499","DOI":"10.4103\/1755-6783.188496","volume":"10","author":"SR Shrivastava","year":"2017","unstructured":"Shrivastava SR, Shrivastava PS, Jegadeesh R. Strengthening research and development activities to effectively contain the epidemics of infectious diseases: World Health Organization. Ann Trop Med Public Health. 2017;10(3):499\u2013500.","journal-title":"Ann Trop Med Public Health"},{"issue":"1","key":"1624_CR36","first-page":"83","volume":"13","author":"NM Thielman","year":"2016","unstructured":"Thielman NM, Cunningham CK, Woods C, Petzold E, Sprenz M, Russell J. Ebola clinical trials: five lessons learned and a way forward. Clin. 2016;13(1):83\u20136.","journal-title":"Clin."},{"issue":"4","key":"1624_CR37","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1097\/CCM.0b013e318275d061","volume":"41","author":"KE Burns","year":"2013","unstructured":"Burns KE, Rizvi L, Tan W, Marshall JC, Pope K. Participation of ICUs in critical care pandemic research: a province wide, cross-sectional survey. Crit Care Med. 2013;41(4):1009\u201316.","journal-title":"Crit Care Med"},{"issue":"7563","key":"1624_CR38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/524029a","volume":"524","author":"T Lang","year":"2015","unstructured":"Lang T. Ebola: embed research in outbreak response. Nature. 2015;524(7563):29\u201331.","journal-title":"Nature."},{"issue":"1","key":"1624_CR39","first-page":"79","volume":"13","author":"AC Levine","year":"2016","unstructured":"Levine AC. Academics are from Mars, humanitarians are from Venus: finding common ground to improve research during humanitarian emergencies. Clin. 2016;13(1):79\u201382.","journal-title":"Clin."},{"key":"1624_CR40","doi-asserted-by":"crossref","unstructured":"Mooney T, Smout E, Leigh B, Greenwood B, Enria L, Ishola D, et al. EBOVAC-Salone: lessons learned from implementing an Ebola vaccine trial in an Ebola-affected country. Clin. 2018;15(5):436\u201343.","DOI":"10.1177\/1740774518780678"},{"issue":"9720","key":"1624_CR41","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0140-6736(10)60068-2","volume":"375","author":"T Walley","year":"2010","unstructured":"Walley T, Davidson P. Research funding in a pandemic. Lancet. 2010;375(9720):1063\u20135.","journal-title":"Lancet."},{"issue":"3","key":"1624_CR42","doi-asserted-by":"crossref","first-page":"98","DOI":"10.15585\/mmwr.su6503a14","volume":"65","author":"MA Widdowson","year":"2016","unstructured":"Widdowson MA, Schrag SJ, Carter RJ, Carr W, Legardy-Williams J, Gibson L, et al. Implementing an Ebola vaccine study - Sierra Leone. MMWR Suppl. 2016;65(3):98\u2013106.","journal-title":"MMWR Suppl"},{"issue":"5 Supplement 1","key":"1624_CR43","first-page":"593","volume":"95","author":"A Idriss","year":"2016","unstructured":"Idriss A, Wertheim RC, Kargbo B. Sierra Leone Trial to Introduce a Vaccine Against Ebola (strive): implementation challenges, successes and lessons learned. Am J Trop Med Hygiene. 2016;95(5 Supplement 1):593.","journal-title":"Am J Trop Med Hygiene"},{"issue":"9","key":"1624_CR44","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1080\/21645515.2016.1272744","volume":"13","author":"M Molyneux","year":"2017","unstructured":"Molyneux M. New ethical considerations in vaccine trials. Hum Vaccines Immunother. 2017;13(9):2160\u20133.","journal-title":"Hum Vaccines Immunother"},{"issue":"6","key":"1624_CR45","first-page":"699","volume":"8","author":"DW Scheifele","year":"2011","unstructured":"Scheifele DW, Marty K, LaJeunesse C, Fan SY, Bjornson G, Langley JM, et al. Strategies for successful rapid trials of influenza vaccine. Clin. 2011;8(6):699\u2013704.","journal-title":"Clin."},{"issue":"16","key":"1624_CR46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta19160","volume":"19","author":"WS Lim","year":"2015","unstructured":"Lim WS, Brittain C, Duley L, Edwards S, Gordon S, Montgomery A, et al. Blinded randomised controlled trial of low-dose Adjuvant Steroids in Adults admitted to hospital with Pandemic influenza (ASAP): a trial \u2018in hibernation\u2019, ready for rapid activation. Health Technol Assess. 2015;19(16):1\u2013viii.","journal-title":"Health Technol Assess"},{"key":"1624_CR47","first-page":"h3740","volume":"351","author":"Ebola ca Suffit Ring Vaccination Trial C","year":"2015","unstructured":"Ebola ca Suffit Ring Vaccination Trial C. The ring vaccination trial: a novel cluster randomised controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola. BMJ. 2015;351:h3740.","journal-title":"BMJ"},{"issue":"1","key":"1624_CR48","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12916-016-0760-x","volume":"14","author":"AM Rojek","year":"2016","unstructured":"Rojek AM, Horby PW. Modernising epidemic science: enabling patient-centred research during epidemics. BMC Med. 2016;14(1):212.","journal-title":"BMC Med"},{"key":"1624_CR49","doi-asserted-by":"crossref","unstructured":"Kho ME, McDonald E, Zytaruk N, Tkaczyk A, Clarke F, Fowler R, et al. Costs of clinical research preparation for the H1N1 pandemic in Canada: a single center, multi-site analysis. American Journal of Respiratory and Critical Care Medicine Conference: American Thoracic Society International Conference, ATS. 2011;183(1 MeetingAbstracts).","DOI":"10.1164\/ajrccm-conference.2011.183.1_MeetingAbstracts.A2387"},{"issue":"1","key":"1624_CR50","first-page":"22","volume":"13","author":"SM Berry","year":"2016","unstructured":"Berry SM, Petzold EA, Dull P, Thielman NM, Cunningham CK, Corey GR, et al. A response adaptive randomization platform trial for efficient evaluation of Ebola virus treatments: a model for pandemic response. Clin. 2016;13(1):22\u201330.","journal-title":"Clin."},{"issue":"1","key":"1624_CR51","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/phe\/phn037","volume":"2","author":"P Calain","year":"2009","unstructured":"Calain P, Fiore N, Poncin M, Hurst SA. Research ethics and international epidemic response: the case of Ebola and Marburg hemorrhagic fevers. Public Health Ethics. 2009;2(1):7\u201329.","journal-title":"Public Health Ethics"},{"issue":"8","key":"1624_CR52","doi-asserted-by":"crossref","first-page":"e1002109","DOI":"10.1371\/journal.pmed.1002109","volume":"13","author":"JP Chretien","year":"2016","unstructured":"Chretien JP, Rivers CM, Johansson MA. Make data sharing routine to prepare for public health emergencies. PLoS Med. 2016;13(8):e1002109.","journal-title":"PLoS Med"},{"key":"1624_CR53","doi-asserted-by":"crossref","first-page":"b4652","DOI":"10.1136\/bmj.b4652","volume":"339","author":"AJ Pollard","year":"2009","unstructured":"Pollard AJ, Reiner A, John T, Sheasby E, Snape M, Faust S, et al. Future of flu vaccines. expediting clinical trials in a pandemic. BMJ. 2009;339:b4652.","journal-title":"BMJ"},{"issue":"9980","key":"1624_CR54","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/S0140-6736(15)60645-6","volume":"385","author":"DL Heymann","year":"2015","unstructured":"Heymann DL, Rodier GR, Ryan MJ. Ebola vaccines: keep the clinical trial protocols on the shelf and ready to roll out. Lancet. 2015;385(9980):1913\u20135.","journal-title":"Lancet."},{"issue":"4 Suppl","key":"1624_CR55","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1097\/CCM.0b013e3181d20c77","volume":"38","author":"RA Fowler","year":"2010","unstructured":"Fowler RA, Webb SA, Rowan KM, Sprung CL, Thompson BT, Randolph AG, et al. Early observational research and registries during the 2009-2010 influenza A pandemic. Crit Care Med. 2010;38(4 Suppl):e120\u201332.","journal-title":"Crit Care Med"},{"key":"1624_CR56","unstructured":"Lie RK, Wendler D. The Guinea Phase III Ebola Vaccine Trial: lessons for research ethics review in public health emergencies. IRB 2017;39(2)."},{"key":"1624_CR57","doi-asserted-by":"crossref","unstructured":"Dunning J, Kennedy SB, Antierens A, Whitehead J, Ciglenecki I, Carson G, et al. Experimental treatment of Ebola virus disease with brincidofovir. PLoS One. 2016;11(9).","DOI":"10.1371\/journal.pone.0162199"},{"issue":"24","key":"1624_CR58","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2807\/1560-7917.ES2014.19.24.20831","volume":"19","author":"NS Crowcroft","year":"2014","unstructured":"Crowcroft NS, Rosella LC, Pakes BN. The ethics of sharing preliminary research findings during public health emergencies: a case study from the 2009 influenza pandemic. Euro Surveill. 2014;19(24):19.","journal-title":"Euro Surveill"},{"key":"1624_CR59","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.socscimed.2015.11.017","volume":"148","author":"F Kombe","year":"2016","unstructured":"Kombe F, Folayan MO, Ambe J, Igonoh A, Abayomi A. Taking the bull by the horns: ethical considerations in the design and implementation of an Ebola virus therapy trial. Soc Sci Med. 2016;148:163\u201370.","journal-title":"Soc Sci Med"},{"key":"1624_CR60","doi-asserted-by":"crossref","unstructured":"Richardson T, Johnston AM, Draper H. A systematic review of Ebola treatment trials to assess the extent to which they adhere to ethical guidelines. PLoS One. 2017;12(1).","DOI":"10.1371\/journal.pone.0168975"},{"issue":"6347","key":"1624_CR61","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1126\/science.aam8334","volume":"357","author":"M Lipsitch","year":"2017","unstructured":"Lipsitch M, Eyal N. Improving vaccine trials in infectious disease emergencies. Science. 2017;357(6347):153\u20136.","journal-title":"Science."},{"issue":"15","key":"1624_CR62","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.vaccine.2017.02.039","volume":"35","author":"X Kurz","year":"2017","unstructured":"Kurz X, Bauchau V, Mahy P, Glismann S, van der Aa LM, Simondon F, et al. The ADVANCE Code of Conduct for collaborative vaccine studies. Vaccine. 2017;35(15):1844\u201355.","journal-title":"Vaccine."},{"key":"1624_CR63","first-page":"170DUMMY","volume":"1","author":"D Whitham","year":"2013","unstructured":"Whitham D, Brittain C, Duley L, Lim WS. Randomised trials during a public health crisis, such as pandemic flu: a case study for a model of \u2018off the shelf\u2019 ready-to-go trials. Trials. 2013;1:170DUMMY.","journal-title":"Trials"},{"issue":"1","key":"1624_CR64","first-page":"101","volume":"13","author":"M Cavaleri","year":"2016","unstructured":"Cavaleri M, Thomson A, Salmonson T, Hemmings RJ. A viewpoint on European Medicines Agency experience with investigational medicinal products for Ebola. Clin. 2016;13(1):101\u20134.","journal-title":"Clin."},{"issue":"2","key":"1624_CR65","first-page":"76","volume":"1","author":"M De Crop","year":"2016","unstructured":"De Crop M, Delamou A, Griensven JV, Ravinetto R. Multiple ethical review in North-South collaborative research: the experience of the Ebola-Tx trial in Guinea. Indian J Med Ethics. 2016;1(2):76\u201382.","journal-title":"Indian J Med Ethics"},{"issue":"3","key":"1624_CR66","doi-asserted-by":"crossref","first-page":"432","DOI":"10.2105\/AJPH.2015.302996","volume":"106","author":"A Rid","year":"2016","unstructured":"Rid A, Miller FG. Ethical rationale for the Ebola \u201cring vaccination\u201d trial design. Am J Public Health. 2016;106(3):432\u20135.","journal-title":"Am J Public Health"},{"key":"1624_CR67","first-page":"431","volume":"1","author":"R Ravinetto","year":"2015","unstructured":"Ravinetto R, De Crop M, Delamou A, Van Griensven J. Multiple ethical review in North-South collaborative research in an emergency context: the experience of the Ebola-Tx trial. Trop Med Int Health. 2015;1:431\u20132.","journal-title":"Trop Med Int Health"},{"issue":"4","key":"1624_CR68","doi-asserted-by":"crossref","first-page":"e1002549","DOI":"10.1371\/journal.pmed.1002549","volume":"15","author":"MA Johansson","year":"2018","unstructured":"Johansson MA, Reich NG, Meyers LA, Lipsitch M. Preprints: an underutilized mechanism to accelerate outbreak science. PLoS Med. 2018;15(4):e1002549.","journal-title":"PLoS Med"},{"issue":"6","key":"1624_CR69","doi-asserted-by":"crossref","first-page":"e0005545","DOI":"10.1371\/journal.pntd.0005545","volume":"11","author":"S Carazo Perez","year":"2017","unstructured":"Carazo Perez S, Folkesson E, Anglaret X, Beavogui AH, Berbain E, Camara AM, et al. Challenges in preparing and implementing a clinical trial at field level in an Ebola emergency: a case study in Guinea, West Africa. PLoS Negl Trop Dis. 2017;11(6):e0005545.","journal-title":"PLoS Negl Trop Dis"},{"issue":"SPEC.ISS 1","key":"1624_CR70","first-page":"52","volume":"388","author":"N Gobat","year":"2016","unstructured":"Gobat N, Gal M, Butler CC, Francis NA, Anthierens S, Bastiaens H, et al. Public attitudes towards research participation during an infectious disease pandemic: a qualitative study across four European countries. Lancet. 2016;388(SPEC.ISS 1):52.","journal-title":"Lancet"},{"key":"1624_CR71","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ijid.2016.02.444","volume":"1","author":"EM Smout","year":"2016","unstructured":"Smout EM, Enria L, Mooney T, Lees S, Watson-Jones D, Greenwood B, et al. Implementing a novel community engagement system during a clinical trial of a candidate Ebola vaccine within an outbreak setting. Int J Infect Dis. 2016;1:191.","journal-title":"Int J Infect Dis"},{"issue":"1","key":"1624_CR72","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1186\/s12889-016-3799-x","volume":"16","author":"L Enria","year":"2016","unstructured":"Enria L, Lees S, Smout E, Mooney T, Tengbeh AF, Leigh B, et al. Power, fairness and trust: understanding and engaging with vaccine trial participants and communities in the setting up the EBOVAC-Salone vaccine trial in Sierra Leone. BMC Public Health. 2016;16(1):1140.","journal-title":"BMC Public Health"},{"issue":"3","key":"1624_CR73","first-page":"640","volume":"39","author":"D Shaw","year":"2017","unstructured":"Shaw D, Elger BS. Publication ethics in public health emergencies. J Public Health (Oxf). 2017;39(3):640\u20133.","journal-title":"J Public Health (Oxf)"},{"issue":"1","key":"1624_CR74","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/hex.12634","volume":"21","author":"NH Gobat","year":"2018","unstructured":"Gobat NH, Gal M, Butler CC, Webb SAR, Francis NA, Stanton H, et al. Talking to the people that really matter about their participation in pandemic clinical research: a qualitative study in four European countries. Health Expect. 2018;21(1):387\u201395.","journal-title":"Health Expect"},{"issue":"6","key":"1624_CR75","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S1473-3099(15)70139-8","volume":"15","author":"SE Bellan","year":"2015","unstructured":"Bellan SE, Pulliam JR, Pearson CA, Champredon D, Fox SJ, Skrip L, et al. Statistical power and validity of Ebola vaccine trials in Sierra Leone: a simulation study of trial design and analysis. Lancet Infect Dis. 2015;15(6):703\u201310.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"1624_CR76","first-page":"57","volume":"13","author":"A Vandebosch","year":"2016","unstructured":"Vandebosch A, Mogg R, Goeyvaerts N, Truyers C, Greenwood B, Watson-Jones D, et al. Simulation-guided phase 3 trial design to evaluate vaccine effectiveness to prevent Ebola virus disease infection: statistical considerations, design rationale, and challenges. Clin. 2016;13(1):57\u201365.","journal-title":"Clin."},{"issue":"6","key":"1624_CR77","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S1473-3099(15)70106-4","volume":"15","author":"S Lanini","year":"2015","unstructured":"Lanini S, Zumla A, Ioannidis JPA, Di Caro A, Krishna S, Gostin L, et al. Are adaptive randomised trials or non-randomised studies the best way to address the Ebola outbreak in West Africa? Lancet Infect Dis. 2015;15(6):738\u201345.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"1624_CR78","first-page":"49","volume":"10","author":"D Schopper","year":"2017","unstructured":"Schopper D, Ravinetto R, Schwartz L, Kamaara E, Sunita S, Segelid MJ, et al. Research ethics governance in times of Ebola. Public Health Ethics. 2017;10(1):49\u201361.","journal-title":"Public Health Ethics."},{"key":"1624_CR79","doi-asserted-by":"crossref","unstructured":"Kummervold PE, Schulz WS, Smout E, Fernandez-Luque L, Larson HJ. Controversial Ebola vaccine trials in Ghana: a thematic analysis of critiques and rebuttals in digital news. BMC Public Health. 2017;17(642).","DOI":"10.1186\/s12889-017-4618-8"},{"key":"1624_CR80","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.socscimed.2018.03.008","volume":"203","author":"AF Tengbeh","year":"2018","unstructured":"Tengbeh AF, Enria L, Smout E, Mooney T, Callaghan M, Ishola D, et al. \u201cWe are the heroes because we are ready to die for this country\u201d: participants\u2019 decision-making and grounded ethics in an Ebola vaccine clinical trial. Soc Sci Med. 2018;203:35\u201342.","journal-title":"Soc Sci Med"},{"key":"1624_CR81","unstructured":"Nuffield Council on Bioethics. Conducting research in the context of global health emergencies: what are the ethical challenges? Nuffield Council on Bioethics. 2016. Available at: https:\/\/www.nuffieldbioethics.org\/wp-content\/uploads\/Research-in-GHEs-note-for-web.pdf (Workshop)."},{"issue":"10088","key":"1624_CR82","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1016\/S0140-6736(17)31635-5","volume":"389","author":"MP Kieny","year":"2017","unstructured":"Kieny MP, Salama P. WHO R&D Blueprint: a global coordination mechanism for R&D preparedness. Lancet. 2017;389(10088):2469\u201370.","journal-title":"Lancet"},{"key":"1624_CR83","doi-asserted-by":"crossref","unstructured":"Gobat N, Amuasi J, Yazdanpanah Y, Sigfrid L, Davies H, Byrne J, et al. Advancing preparedness for clinical research during infectious disease epidemics. ERJ Open Res. 2019;5.","DOI":"10.1183\/23120541.00227-2018"},{"issue":"1","key":"1624_CR84","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1146\/annurev-micro-090817-062414","volume":"72","author":"H Feldmann","year":"2018","unstructured":"Feldmann H, Feldmann F, Marzi A. Ebola: lessons on vaccine development. Annu Rev Microbiol. 2018;72(1):423\u201346.","journal-title":"Annu Rev Microbiol"},{"key":"1624_CR85","doi-asserted-by":"crossref","DOI":"10.5040\/9781350225701","volume-title":"Understanding West Africa\u2019s Ebola epidemic: towards a political economy","author":"I Abdullah","year":"2017","unstructured":"Abdullah I, Rashid IOD, African Leadership C. Understanding West Africa\u2019s Ebola epidemic: towards a political economy 2017."},{"key":"1624_CR86","doi-asserted-by":"crossref","unstructured":"Simpson CR, Beever D, Challen K, De Angelis D, Fragaszy E, Goodacre S, et al. The UK\u2019s pandemic influenza research portfolio: a model for future research on emerging infections. Lancet Infect Dis. 2019;19(8):E295-300.","DOI":"10.1016\/S1473-3099(18)30786-2"},{"key":"1624_CR87","unstructured":"The World Health Organisation. A research and development blueprint for action to prevent epidemics: WHO; 2018. Available from: https:\/\/www.who.int\/blueprint\/en\/. [cited 2019 Oct.]."},{"issue":"8","key":"1624_CR88","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/s41564-018-0206-7","volume":"3","author":"P Horby","year":"2018","unstructured":"Horby P. Improving preparedness for the next flu pandemic. Nat Microbiol. 2018;3(8):848\u201350.","journal-title":"Nat Microbiol"},{"key":"1624_CR89","unstructured":"PREPARE. Platform for European Preparedness Against (Re-)emerging Epidemics: PREPARE; 2019. Available from: https:\/\/www.prepare-europe.eu\/. [cited 2019 Nov.]."},{"key":"1624_CR90","unstructured":"ALLERT. The African Coalition for Epidemic Research, Response and Training: ALLERT; 2019. Available from: https:\/\/www.alerrt.global\/. [cited 2019 Nov.]."},{"key":"1624_CR91","unstructured":"Pandora-ID-Net. The Pan-African Network For Rapid Research, Response, Relief and Preparedness for Infectious Disease Epidemics: Pandora-ID-Net; Available from: https:\/\/www.pandora-id.net\/. [cited 2019 Dec.]."},{"key":"1624_CR92","unstructured":"WHO. Preliminary results on the efficacy of rVSV-ZEBOV-GP Ebola vaccine using the ring vaccination strategy in the control of an Ebola outbreak in the Democratic Republic of the Congo: an example of integration of research into epidemic response. The World Health Organisation; 2019. Available from: https:\/\/www.who.int\/csr\/resources\/publications\/ebola\/ebola-ring-vaccination-results-12-april-2019.pdf. [cited 2019 Dec.]."},{"issue":"24","key":"1624_CR93","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMoa1910993","volume":"381","author":"S Mulangu","year":"2019","unstructured":"Mulangu S, Dodd LE, Davey RT, Tshiani Mbaya O, Proschan M, Mukadi D, et al. A randomized, controlled trial of Ebola virus disease therapeutics. N Engl J Med. 2019;381(24):2293\u2013303.","journal-title":"N Engl J Med"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-020-01624-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-020-01624-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-020-01624-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T05:43:50Z","timestamp":1667108630000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-020-01624-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,25]]},"references-count":93,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1624"],"URL":"https:\/\/doi.org\/10.1186\/s12916-020-01624-8","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,25]]},"assertion":[{"value":"12 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"We declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"190"}}